We investigated the uptake of imipramine (IMP) in highly purified lysosomes
from rat liver and its inhibition by a variety of basic drugs in vitro. Th
e uptake of [H-3]IMP into lysosomes peaked in less than 20 s, showing littl
e temperature dependency or countertransport phenomena. It was accelerated
by increase of extralysosomal pH, stimulated by Mg2+-ATP in KCl buffer, and
suppressed by acidic ionophores. However, the uptake of [H-3]IMP in lysoso
mes was approximately 140-fold higher than the value expected from the pH-p
artition theory. IMP and other weak lipophilic bases like chlorpromazine an
d propranolol raised the intralysosomal pH, and their potency was stronger
than that of NH4Cl, a typical pH-perturbing weak base. A variety of basic d
rugs inhibited the uptakes of [H-3]IMP and [C-14]methylamine into lysosomes
, their 50% inhibitory concentrations (IC50) being almost the same for [H-3
]IMP and [C-14]methylamine uptake (r = 0.842). A high correlation (r = 0.94
6) was observed between the IC50 values (for the inhibition of [H-3]IMP upt
ake) and the lipophilicity (P-oct values). These results suggest that the a
ccumulation of lipophilic basic drugs is driven primarily by the transmembr
ane pH difference (pH-partition theory) but with the involvement of some ad
ditional mechanism(s) related to drug lipophilicity, possibly binding (part
ition or adsorption) to lipophilic substance(s) and/or aggregation within l
ysosomes. Based on this idea, we have established a model that described an
d successfully simulated the weak base-induced pH increase, the accumulatio
n of a lipophilic weak base (IMP), and the inhibition of accumulation of IM
P by lipophilic basic drugs.